Drug Trial Radar · NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
990
Planned (sponsor's estimate)
Start
Mar 23, 2026
Primary completion
Jun 2030
Study completion Jul 2030
Sponsor
- Lead sponsor
- Zenas BioPharma (USA), LLCIndustry
- Sponsor type
- Industry
- First posted
- Dec 23, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Orelabrutinib is a CNS-penetrable BTK inhibitor. This is a phase 3, randomized, double-blind, parallel-group, multicenter study to evaluate the efficacy and safety of orelabrutinib compared with placebo in patients with non-active Secondary Progress MS. Patients will be treated for approximately 24 to 60 months, with a minimum treatment duration of 12 months. The study will enroll approximately 990 subjects in a 2:1 randomization (orelabrutinib: placebo), globally.
Conditions
- Secondary Progressive Multiple Sclerosis
Interventions
OrelabrutinibDrug
Orelabrutinib orally
PlaceboDrug
Placebo orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to onset of confirmed disability progression (CDP) events, confirmed over at least 24 weeksTime frame: Up to approximately 120 weeks
Locations
98 sites in 20 countries. Site status is shown where the registry gives one.
Arizona Neuroscience Research, LLC
Phoenix, Arizona · Recruiting
Perseverance Research Center, LLC (PRC)
Scottsdale, Arizona · Recruiting
Fullerton Neurology and Headache Center
Fullerton, California · Recruiting
Harbor-UCLA Medical Center - The Lundquist Institute (Los Angeles Biomedical Research Institute (LA BioMed))
Torrance, California · Recruiting
Regina Berkovich MD, PhD Inc
West Hollywood, California · Recruiting
SFM Clinical Research, LLC
Boca Raton, Florida · Recruiting
Nova Clinical Research, LLC
Bradenton, Florida · Recruiting
MS and Neuromuscular Center of Excellence
Clearwater, Florida · Recruiting
Neurology Associates
Maitland, Florida · Recruiting
Aqualane Clinical Research
Naples, Florida · Recruiting
University of South Florida Department of Neurology - MS Division
Tampa, Florida · Recruiting
Josephson Wallack Munshower Neurology, Pc Suite 225
Indianapolis, Indiana · Recruiting
University of Kansas Medical Center
Kansas City, Kansas · Recruiting
KC Research Center, PA Neurology Research Dept
Roeland Park, Kansas · Recruiting
Boston Clinical Trials
Boston, Massachusetts · Withdrawn
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts · Recruiting
Profound Research LLC at Oakland Neurology Center
Rochester Hills, Michigan · Recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
University Of New Mexico School Of Medicine
Albuquerque, New Mexico · Recruiting
Mount Sinai Medical Center
New York, New York · Recruiting
The Ohio State University Wexner Medical Center (OSUWMC)
Columbus, Ohio · Recruiting
The Boster Center for Multiple Sclerosis
Columbus, Ohio · Recruiting
OMRF Multiple Sclerosis Center of Excellence
Oklahoma City, Oklahoma · Recruiting
Premier Neurology
Greenville, South Carolina · Recruiting
Neurology Clinic, P.C.
Cordova, Tennessee · Recruiting
Lone Star Neurology
San Antonio, Texas · Recruiting
Texas Institute for Neurological Disorders - Sherman
Sherman, Texas · Recruiting
Southern Neurology Suite 2
Kogarah, New South Wales, Australia · Recruiting
DCC Neoclinic - Sofia
Sovet, Belgium · Recruiting
MS-Netwerk Limburg - Revalidatie
Overpelt, Limburg, Belgium · Recruiting
Avis Medica Hospital Pleven
Pleven, Bulgaria · Recruiting
Medical Center Nevrocentrum
Plovdiv, Plovdiv, Bulgaria · Recruiting
Medical Center Hera EOOD
Sofia, Sofia, Bulgaria · Recruiting
Diagnostic and Consultative Center Convex
Sofia, Sofia, Bulgaria · Recruiting
Medical Center Medica Plus OOD
Veliko Tarnovo, Tarnovo, Bulgaria · Recruiting
Klinicki Bolnicki Centar Zagreb-Rebro
Zagreb, Croatia · Recruiting
NEUROHK, s.r.o.
Choceň, Czechia · Recruiting
Regional Hospital Jihlava
Jihlava, Czechia · Recruiting
Astra clinic (Clinic4U)
Tallinn, Harju, Estonia · Recruiting
CHU Brest Hospital Cavale
Pordic, Brest, France · Recruiting
Showing 40 of 98 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.